Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 431369
                    [Title] => Study shows CVD protection for Pinoys, other Asians
                    [Summary] => 
Majority of patients with cardiovascular disease (CVD) leading to heart attack and stroke do not receive appropriate treatment for various reasons.
                    [DatePublished] => 2009-01-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 424423
                    [Title] => Filipinos, other Asians benefit from telmisartan
                    [Summary] => 
The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) showed very promising results in Asian patients, as well as non-Asian patients, at high risk of cardiovascular disease (CVD).
                    [DatePublished] => 2008-12-18 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

GREAT WALL-INTERNATIONAL CARDIOLOGY CONGRESS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 431369
                    [Title] => Study shows CVD protection for Pinoys, other Asians
                    [Summary] => 
Majority of patients with cardiovascular disease (CVD) leading to heart attack and stroke do not receive appropriate treatment for various reasons.
                    [DatePublished] => 2009-01-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 424423
                    [Title] => Filipinos, other Asians benefit from telmisartan
                    [Summary] => 
The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) showed very promising results in Asian patients, as well as non-Asian patients, at high risk of cardiovascular disease (CVD).
                    [DatePublished] => 2008-12-18 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Study shows CVD protection for Pinoys, other Asians

January 15, 2009 - 12:00am

Majority of patients with cardiovascular disease (CVD) leading to heart attack and stroke do not receive appropriate treatment for various reasons.

Science and Environment

Filipinos, other Asians benefit from telmisartan

December 18, 2008 - 12:00am

The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) showed very promising results in Asian patients, as well as non-Asian patients, at high risk of cardiovascular disease...

Science and Environment